Geriatric psychiatry panel
Board-certified psychiatrists or geriatricians with clinical focus on late-life mental health and geriatric psychopharmacology.
Scope
The Beers Criteria reference; the antidepressants-for-elderly and antipsychotics-for-elderly guides; the lecanemab and donanemab state-of-practice piece; anticholinergic burden guidance.
Pages owned by this panel
- /guides/beers-criteria-psychiatric-meds
- /guides/antidepressants-for-elderly
- /guides/antipsychotics-for-elderly
- /side-effects/anticholinergic-burden
- /tools/anticholinergic-burden-calculator
- /tools/beers-criteria-checker
- /state-of-practice/lecanemab-donanemab-anti-amyloid
- /medications/lecanemab
- /medications/donanemab
- /medications/donepezil
- /medications/rivastigmine
- /medications/galantamine
- /medications/memantine
Current members
This panel currently has 1 named seat open. No specialist reviewer has joined yet.
A reviewer's name only appears on this page after they have (a) agreed in writing to participate and (b) reviewed and approved at least one page in the scope above. We do not pad panels with unaffiliated names.
Join this panel
If you are a board-certified specialist in geriatric psychiatry and would like to review pages in the scope above, see the contribute page for the full application process, or email [email protected] with the subject line "Geriatric psychiatry panel: application."
Reviewers receive: a public profile page at /reviewers/<your-slug>/, named credit on every page they review, a shareable badge for their institutional bio or CV, and a canonical inbound link from PsychiatryRx to their broader academic identity. Reviewers do not receive compensation, referral revenue, or any commercial relationship with the site.